tirzepatide and fda Wins Approval for Weight Loss Sandoz Moves Closer to Generic

Recent studies report visual side effects, which have the eye care world wondering if GLP-1s are a little too good to be true.

Learn whats required for GLP-1 weight loss programsget started today.

To help ensure an expanded healthy lifespan for as many people as possible worldwide, there is a need to prevent or manage a number of prevalent chronic diseases directly and indirectly closely related to aging, including diabetes and obesity

Gymnema (Gymnema sylvestre) has a long history in Ayurvedic medicine

Survodutide Survodutide combines GLP-1 and glucagon receptor agonism and may offer benefits for both obesity and metabolic-associated steatotic liver disease

Materials and methods The effects of long-term exposures to tirzepatide, a novel dual GIP/GLP-1 receptor agonist, on neurotoxicity and behavioral changes in the D-galactose/aluminium chloride (D-gal/AlCl3)-induced rats' AD-like pathological model were evaluated